Ronald Allen Louks - Sep 10, 2021 Form 4 Insider Report for NantHealth, Inc. (NHIQ)

Signature
/s/ Brandon Villery, as Attorney-in-Fact
Stock symbol
NHIQ
Transactions as of
Sep 10, 2021
Transactions value $
-$23,994
Form type
4
Date filed
9/14/2021, 09:11 PM
Previous filing
Sep 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHIQ Common Stock Options Exercise $4.03K +7.32K +3.24% $0.55 233K Sep 10, 2021 Direct
transaction NHIQ Common Stock Sale -$15K -7.32K -3.14% $2.05 226K Sep 10, 2021 Direct F1
transaction NHIQ Common Stock Options Exercise $5.06K +9.2K +4.07% $0.55 235K Sep 13, 2021 Direct
transaction NHIQ Common Stock Sale -$18K -9.2K -3.91% $1.96 226K Sep 13, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHIQ Stock Option (right to buy) Options Exercise $0 -7.32K -1.39% $0.00 520K Sep 10, 2021 Common Stock 7.32K $0.55 Direct F3
transaction NHIQ Stock Option (right to buy) Options Exercise $0 -9.2K -1.77% $0.00 511K Sep 13, 2021 Common Stock 9.2K $0.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 7,320 shares sold in the price range of $1.98 to $2.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Represents the weighted average share price of an aggregate total of 9,200 shares sold in the price range of $1.96 to $1.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date.